Pradžia › Širdies priepuolis › Florida
Širdies priepuolis klinikiniai tyrimai Florida
5 tyrimai dėl Širdies priepuolis ieško dalyvių vietose Florida.
Miestai Florida
Oficialus tyrimo tekstas (anglų kalba)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- - Boca Raton Regional - Research Physicians Network Alliance, Boca Raton
- Nova Clinical Research, LLC, Bradenton
- South Florida Nephrology Group, PA, Coral Springs
- ir dar 14
Renkami dalyviai2/3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-21 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Excel Medical Clinical Trials LLC, Boca Raton
- Bay Area Cardiology Assoc, Brandon
- Jacksonville Center for Clinical Research, Jacksonville
- ir dar 5
Renkami dalyviai3 fazė
Amžius nuo 18 iki 100 · Visoms lytims · Atnaujinta 2026-09-04 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Excel Medical Clinical Trials, Boca Raton
- Clearwater Cardiovascular Consultants, Clearwater
- Jacksonville Center for Clinical Research, Jacksonville
- ir dar 14
Renkami dalyviai3 fazė
Amžius nuo 50 iki 105 · Visoms lytims · Atnaujinta 2026-08-21 · NCT07136012Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- University of Florida - Gainesville, Gainesville
- Tampa General Hospital, Tampa
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-24 · NCT04774159Focused Orticumab Research for Treating Inflammation in Coronary Arteries
- Abcentra Investigational Site, Boca Raton
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-01-27 · NCT06927739Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.